UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

Molecular cancer, 2018-02, Vol.17 (1), p.33-33, Article 33

2018

Volltextzugriff (PDF)

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Cancer discovery, 2017-07, Vol.7 (7), p.694-703

2017

Volltextzugriff (PDF)

Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma

Nature medicine, 2019-11, Vol.25 (11), p.1783-1795

2019

Volltextzugriff (PDF)

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery

Cancer letters, 2019-07, Vol.453, p.21-33

2019

Volltextzugriff (PDF)

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

Molecular cancer, 2024-04, Vol.23 (1), p.78-78, Article 78

2024

Volltextzugriff (PDF)

Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (22), p.5744-5756

2012

Volltextzugriff (PDF)

Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma

Liver international, 2019-05, Vol.39 (S1), p.79-97

2019

Volltextzugriff (PDF)

Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis

PLoS genetics, 2012-05, Vol.8 (5), p.e1002650

2012

Volltextzugriff (PDF)

Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research

Cancers, 2019-11, Vol.11 (12), p.1868

2019

Volltextzugriff (PDF)

All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS

Molecular & cellular oncology, 2017-05, Vol.4 (3), p.e1314239-e1314239

2017

Volltextzugriff (PDF)

A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2275-2285

2008

Volltextzugriff (PDF)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

EBioMedicine, 2020-03, Vol.53, p.102683-102683, Article 102683

2020

Volltextzugriff (PDF)

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.23-23, Article 23

2017

Volltextzugriff (PDF)

Molecular Analysis of a Multistep Lung Cancer Model Induced by Chronic Inflammation Reveals Epigenetic Regulation of p16, Activation of the DNA Damage Response Pathway

Neoplasia (New York, N.Y.), 2007-10, Vol.9 (10), p.840,IN9-852,IN12

2007

Volltextzugriff (PDF)

RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner

Molecular oncology, 2014-03, Vol.8 (2), p.196-206

2014

Volltextzugriff (PDF)

EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model

Journal of molecular medicine (Berlin, Germany), 2007-09, Vol.85 (9), p.1015-1029

2007

Volltextzugriff (PDF)

Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients

Clinical cancer research, 2004-06, Vol.10 (11), p.3639-3649

2004

Volltextzugriff (PDF)

Tumor–stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models

Clinical & experimental metastasis, 2011-12, Vol.28 (8), p.779-791

2011

Volltextzugriff (PDF)

Altered expression of adhesion molecules and epithelial–mesenchymal transition in silica-induced rat lung carcinogenesis

Laboratory investigation, 2004-08, Vol.84 (8), p.999-1012

2004

Volltextzugriff (PDF)

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential

Oncogene, 2002-06, Vol.21 (28), p.4435-4447

2002

Volltextzugriff (PDF)

Bone metastases in lung cancer. Potential novel approaches to therapy

American journal of respiratory and critical care medicine, 2015-10, Vol.192 (7), p.799-809

2015

Volltextzugriff (PDF)

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

Nature (London), 2021-02, Vol.590 (7846), p.504-508

2021

Volltextzugriff (PDF)

Liver Kinase B1 (LKB1) Loss Has its p-ERKs: ERK Inactivation as a Vulnerability in NSCLC With LKB1 Mutations

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.311-313

2020

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo

Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma

Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis

Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research

All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS

Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells

A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

Molecular Analysis of a Multistep Lung Cancer Model Induced by Chronic Inflammation Reveals Epigenetic Regulation of p16, Activation of the DNA Damage Response Pathway

RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner

EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model

Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients

Tumor–stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models

Altered expression of adhesion molecules and epithelial–mesenchymal transition in silica-induced rat lung carcinogenesis

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential

Bone metastases in lung cancer. Potential novel approaches to therapy

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

Liver Kinase B1 (LKB1) Loss Has its p-ERKs: ERK Inactivation as a Vulnerability in NSCLC With LKB1 Mutations

Suchergebnisse filtern